Overview of Mitochondrial E3 Ubiquitin Ligase MITOL/MARCH5 from Molecular Mechanisms to Diseases
The molecular pathology of diseases seen from the mitochondrial axis has become more complex with the progression of research. A variety of factors, including the failure of mitochondrial dynamics and quality control, have made it extremely difficult to narrow down drug discovery targets. We have id...
Main Authors: | Isshin Shiiba, Keisuke Takeda, Shun Nagashima, Shigeru Yanagi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-05-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/11/3781 |
Similar Items
-
Mitochondrial retrograde signaling to the endoplasmic-reticulum regulates unfolded protein responses
by: Keisuke Takeda, et al.
Published: (2019-11-01) -
Role of the Mitochondrial E3 Ubiquitin Ligases as Possible Therapeutic Targets in Cancer Therapy
by: Jacopo Di Gregorio, et al.
Published: (2023-12-01) -
Progress on Poxvirus E3 Ubiquitin Ligases and Adaptor Proteins
by: Haoran Cui, et al.
Published: (2021-12-01) -
Physiological substrates and ontogeny-specific expression of the ubiquitin ligases MARCH1 and MARCH8
by: Patrick Schriek, et al.
Published: (2021-01-01) -
Irisin attenuates myocardial ischemia/reperfusion‐induced cardiac dysfunction by regulating ER‐mitochondria interaction through a mitochondrial ubiquitin ligase‐dependent mechanism
by: Linhe Lu, et al.
Published: (2020-09-01)